Statement on the safety of synthetic l‐ergothioneine as a novel food – supplementary dietary exposure and safety assessment for infants and young children, pregnant and breastfeeding women. (13th November 2017)
- Record Type:
- Journal Article
- Title:
- Statement on the safety of synthetic l‐ergothioneine as a novel food – supplementary dietary exposure and safety assessment for infants and young children, pregnant and breastfeeding women. (13th November 2017)
- Main Title:
- Statement on the safety of synthetic l‐ergothioneine as a novel food – supplementary dietary exposure and safety assessment for infants and young children, pregnant and breastfeeding women
- Authors:
- Turck, Dominique
Bresson, Jean‐Louis
Burlingame, Barbara
Dean, Tara
Fairweather‐Tait, Susan
Heinonen, Marina
Hirsch‐Ernst, Karen Ildico
Mangelsdorf, Inge
McArdle, Harry J
Naska, Androniki
Neuhäuser‐Berthold, Monika
Nowicka, Grażyna
Pentieva, Kristina
Sanz, Yolanda
Siani, Alfonso
Sjödin, Anders
Stern, Martin
Tomé, Daniel
Vinceti, Marco
Willatts, Peter
Engel, Karl‐Heinz
Marchelli, Rosangela
Pöting, Annette
Poulsen, Morten
Schlatter, Josef Rudolf
Ackerl, Reinhard
van Loveren, Henk - Abstract:
- Abstract: Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to provide a supplementary dietary exposure and safety assessment of syntheticl ‐ergothioneine for those groups of the population which had been excluded by the applicant in the original application, i.e. infants and young children (i.e. toddlers), pregnant and breastfeeding women. Thus, intake estimates were calculated for these population groups and the following maximum anticipated daily intakes ofl ‐ergothioneine from the NF, in addition to the background diet, were calculated: 2.82 mg/kg body weight (bw) per day for infants, 3.39 mg/kg bw per day for toddlers and 1.31 mg/kg bw per day for adults including pregnant and breastfeeding women. The Panel considers that based on the overall toxicological data the no‐observed‐adverse‐effect level (NOAEL) of 800 mg/kg bw per day as established in the original assessment also pertains to pregnant and breastfeeding women as well as to young children (i.e. toddlers) and infants. The corresponding margins of exposure (i.e. the ratio between the NOAEL and the maximum anticipated daily intakes) are 284 for infants, 236 for young children and 610 for pregnant and breastfeeding women. These margins of exposure are considered sufficient. The Panel concludes that the novel food, syntheticl ‐ergothioneine, is safe under the proposed uses and use levels for infants, young children (i.e. toddlers) andAbstract: Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to provide a supplementary dietary exposure and safety assessment of syntheticl ‐ergothioneine for those groups of the population which had been excluded by the applicant in the original application, i.e. infants and young children (i.e. toddlers), pregnant and breastfeeding women. Thus, intake estimates were calculated for these population groups and the following maximum anticipated daily intakes ofl ‐ergothioneine from the NF, in addition to the background diet, were calculated: 2.82 mg/kg body weight (bw) per day for infants, 3.39 mg/kg bw per day for toddlers and 1.31 mg/kg bw per day for adults including pregnant and breastfeeding women. The Panel considers that based on the overall toxicological data the no‐observed‐adverse‐effect level (NOAEL) of 800 mg/kg bw per day as established in the original assessment also pertains to pregnant and breastfeeding women as well as to young children (i.e. toddlers) and infants. The corresponding margins of exposure (i.e. the ratio between the NOAEL and the maximum anticipated daily intakes) are 284 for infants, 236 for young children and 610 for pregnant and breastfeeding women. These margins of exposure are considered sufficient. The Panel concludes that the novel food, syntheticl ‐ergothioneine, is safe under the proposed uses and use levels for infants, young children (i.e. toddlers) and pregnant and breastfeeding women. … (more)
- Is Part Of:
- EFSA journal. Volume 15:Number 11(2017)
- Journal:
- EFSA journal
- Issue:
- Volume 15:Number 11(2017)
- Issue Display:
- Volume 15, Issue 11 (2017)
- Year:
- 2017
- Volume:
- 15
- Issue:
- 11
- Issue Sort Value:
- 2017-0015-0011-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2017-11-13
- Subjects:
- l‐ergothioneine -- novel foods -- food supplements
Food -- Europe -- Safety measures -- Periodicals
Food Safety
Food -- Safety measures
Europe
Periodicals
Periodicals
Fulltext
Government Publications, International
Internet Resources
Periodicals
Periodicals
363.19209405 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1831-4732 ↗
- DOI:
- 10.2903/j.efsa.2017.5060 ↗
- Languages:
- English
- ISSNs:
- 1831-4732
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 11772.xml